APHEXDA
- Product NDC
- 73441-062
- 11-digit product format
- 734410062
- Labeler code
- 73441
- Product ID
- 73441-062_799be625-4029-451b-85f8-dc430ffb2dd7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- MOTIXAFORTIDE
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- SUBCUTANEOUS
- Labeler
- Gamida Cell Inc.
- Application
- NDA217159
- Marketing category
- NDA
- Marketing start
- 2025-06-15
- Substance
- MOTIXAFORTIDE ACETATE
- Active strength
- 62 mg/1.7mL
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- APHEXDA
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| MOTIXAFORTIDE ACETATE | 62 mg/1.7mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 3ZPX60DV8A |
| Rxcui | 2664901, 2664906 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 73441-062-01 | APHEXDA | 1 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 1 | | 4 |
| 73441-062-01 | APHEXDA | 1.7 mL in 1 VIAL, GLASS | INJECTION, POWDER, LYOPHILIZED, | 1.7 | | 4 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 73441-062-01 | 73441006201 | 1 VIAL, GLASS in 1 CARTON (73441-062-01) / 1.7 mL in 1 VIAL, GLASS | 2025-06-15 | No | No | Current |